Literature DB >> 7910278

Active or recent parvovirus B19 infection in children with Kawasaki disease.

G Nigro1, M Zerbini, A Krzysztofiak, G Gentilomi, M A Porcaro, T Mango, M Musiani.   

Abstract

Because parvovirus B19 occasionally causes some of the features typical of Kawasaki disease, we investigated B19 involvement in 15 children with Kawasaki disease. Active or recent B19 infection, as shown by B19-DNAaemia, positive B19-specific IgM antibodies, or both, was diagnosed in 10 patients (67%). A high frequency of all major criteria for diagnosis of Kawasaki disease (60%), anaemia (60%), coronary aneurysms (30%), and arthropathy (30%) was found in children with B19-associated Kawasaki disease. Thus B19 may have a pathogenic role in the development of Kawasaki disease, with other predisposing factors.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7910278     DOI: 10.1016/s0140-6736(94)92154-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  26 in total

1.  Depression in pregnant and postnatal women: an evidence-based approach to treatment in primary care.

Authors:  L Appleby; G Koren; D Sharp
Journal:  Br J Gen Pract       Date:  1999-10       Impact factor: 5.386

2.  Kawasaki disease--a diagnostic challenge.

Authors:  A Harnden
Journal:  Br J Gen Pract       Date:  1999-10       Impact factor: 5.386

Review 3.  Genetic and environmental factors in polymyalgia rheumatica.

Authors:  M A Cimmino
Journal:  Ann Rheum Dis       Date:  1997-10       Impact factor: 19.103

4.  Increased levels of circulating fibroblast growth factor 21 in children with Kawasaki disease.

Authors:  Yue Peng; Qiongfei Pei; Siqi Feng; Ya Su; Ruixi Liu; Qijian Yi; Pengfei Guo
Journal:  Clin Exp Med       Date:  2019-09-03       Impact factor: 3.984

5.  Kawasaki disease associated with parvovirus B19 infection.

Authors:  J M Holm; L K Hansen; H Oxhøj
Journal:  Eur J Pediatr       Date:  1995-08       Impact factor: 3.183

Review 6.  Parvovirus B19: an expanding spectrum of disease.

Authors:  B Cohen
Journal:  BMJ       Date:  1995-12-09

7.  Modest truncation of the major capsid protein abrogates B19 parvovirus capsid formation.

Authors:  M Kawase; M Momoeda; N S Young; S Kajigaya
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

8.  Parvovirus B19 infection, hepatitis C virus infection, and mixed cryoglobulinaemia.

Authors:  P Cacoub; N Boukli; P Hausfater; A Garbarg-Chenon; P Ghillani; V Thibault; L Musset; J M Huraux; J C Piette
Journal:  Ann Rheum Dis       Date:  1998-07       Impact factor: 19.103

Review 9.  Parvovirus B19 infection.

Authors:  J R Kerr
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-01       Impact factor: 3.267

Review 10.  Human parvovirus B19.

Authors:  Erik D Heegaard; Kevin E Brown
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.